Advances in drug development, including new molecules, personalized therapies, and increasingly sensitive formulations, are reshaping the role of packaging in the pharmaceutical industry. Packaging is no longer expected merely to isolate the product from external factors; it is now required to actively control risks such as moisture, oxygen exposure, and chemical contamination.
Packaging Directly Contributes to Product Performance
One of the most prominent trends in the sector is the shift from packaging as a passive container to packaging as an active protection system. For solid dosage forms such as tablets and capsules, product stability and shelf life are now central to packaging design decisions.
Badre Hammond of Aptar CSP Technologies summarizes this shift as follows:
“Packaging is no longer just enclosing the product. It actively manages critical risks such as moisture and oxygen, directly supporting product performance.”
Another key requirement is compatibility with existing production lines. Packaging solutions that support high-speed manufacturing while meeting regulatory standards are becoming the preferred choice for pharmaceutical manufacturers.
Sustainability Becomes a Starting Point for Design
Sustainability is no longer an added value but a core design criterion in pharmaceutical packaging. Reducing plastic use, adopting recyclable materials, and moving toward mono-material structures are rapidly gaining momentum across the industry.
Ward Smith of Keystone Folding Box Co. highlights this shift:
“Sustainability now directly influences every decision made in packaging design.”
Integrating features such as child-resistant and tamper-evident functions directly into packaging structures, rather than adding extra components, helps reduce material usage while improving recyclability.
Digital Information Becomes an Integral Part of Packaging
The information layer of packaging is also undergoing a major transformation. QR codes and digital labeling solutions are enabling clearer, more transparent access to product information, usage instructions, and regulatory data.
Dexter Tjoa, CEO of Tjoapack, explains:
“The real transformation in packaging is not just about materials, but about expanding the scope of information provided.”
These digital tools are becoming particularly valuable in clinical trials, supporting dose tracking and improving patient adherence.
Packaging Lines Become More Flexible and Data-Driven
Packaging machinery is evolving to meet these new demands. Faster systems that can be easily adapted to different products and provide real-time production data are gaining importance. Traceability and process reliability are now among the key criteria guiding equipment investments.
Supply Chains Are Being Strengthened Against Risk
Geopolitical uncertainty and global supply disruptions are pushing companies away from single-source dependency. Regional sourcing strategies and alternative supply networks are playing an increasingly important role in risk management for packaging procurement.
Packaging Becomes Part of the Product Strategy
Looking ahead, pharmaceutical packaging is no longer viewed simply as a cost item. Instead, it is emerging as a strategic component of product safety, patient health, and regulatory compliance. The solutions that will stand out are those that address real challenges clearly, remain scalable, and integrate seamlessly into existing manufacturing processes.
